Research Paper Volume 15, Issue 17 pp 8664—8691
Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
Figure 5. Results of GSEA. (A) GO functional annotation of KIAA1429 in pan-cancer. (B) KEGG pathway analysis of KIAA1429 in pan-cancer. Curves of different colors show different functions or pathways regulated in different cancers.